The BridgeTech Program will be holding its main event of the year, the BridgeTech Symposium, for its inaugural cohort at Luna Park in Sydney.
The 80 participants who have been taking part in the BridgeTech Program, which provides training in the complexities of medical device commercialisation, will congregate at Luna Park to hear from leading MedTech entrepreneurs.
Participants will hear talks and case studies from Australian and international leaders. Amongst the line-up of over 25 speakers are:
- Carl Van Himbeeck, Head of Platforms and Technology, Cochlear International;
- George Faithful, VP of Regulatory and Government Affairs, Stryker;
- Dr Thomas Gaass, Senior Scientist MP, Siemens Healthineers; and
- Michael Nilsson, Director, The Hunter Medical Research Institute.
Other speakers at the 3-day program will include founders and CEOs of medical device startups, IP advisors, regulatory experts, business development professionals, clinical trials specialists, funding experts and investment groups who each play their role in the process of the medical device commercialisation.
Building on the online training modules and the seminar series, the BridgeTech Symposium augments the theoretical part of the program with a practical and interactive workshop.
The symposium aims to provide a real-world experience for participants with the inclusion of the ‘Commercialisation Experience’ – a group pitching session that is delivered to roaming industry professionals who give feedback on their approaches and proposed ‘deals’.
The BridgeTech Program draws upon its consortium members to provide input and advice in the construction and delivery of the course.
The BridgeTech Consortium is made up of universities, industry associations, MedTech companies and investment groups.
According to Professor Lyn Griffiths, Director of The BridgeTech Program and Executive Director of QUT’s Institute of Health and Biomedical Innovation, “With the inclusion of 20 companies, universities and industry associations, it is clear that we are serious about driving the growth and expansion of this exciting field of life science."
The BridgeTech Program is supported by MTPConnect. MTPConnect is providing industry matched funding to run the program in order to continue to build the knowledge base of the sector and further upskill an already thriving industry.